Fineotex Chemical quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	377	137	+174.8%
EBITDA	59.1	25.2	+134.7%
EBITDA margin	15.7%	18.4%	−2.7 pts
Profit before tax	64.7	31.5	+105.6%
Net profit	48.2	25.0	+92.6%
EPS	₹0.41	₹2.18	−81.2%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	377	314	184	138	137	120	126	146	142	153	138	145	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	10.1	9.5	6.7	7.7	9.1	7.5	5.0	6.9	4.9	4.1	4.9	3.8
	387	323	190	145	146	127	131	153	147	157	143	149
	248	225	117	88.3	82.8	83.5	79.3	83.0	93.0	95.6	78.9	83.9
	0.0	0.9	6.0	2.6	8.6	−4.4	2.0	5.0	0.3	3.2	3.1	6.5
	−5.1	−3.1	−3.6	−6.2	−0.2	−2.7	−7.2	2.0	−6.2	−3.6	−1.0	−1.4
	26.8	17.4	10.3	6.5	6.2	6.5	6.1	6.1	5.6	5.5	5.5	5.0
	0.1	0.6	0.2	0.3	0.2	0.4	0.2	0.2	0.2	0.6	0.3	0.3
	4.4	4.4	3.3	3.0	2.7	2.0	2.6	2.4	2.2	1.9	1.4	1.4
	47.4	30.1	19.6	15.4	14.6	15.6	11.5	13.2	13.9	14.0	11.6	12.9
	322	275	152	110	115	101	94.4	112	109	117	99.8	109
	59.1	43.7	34.8	31.0	25.2	21.3	34.3	36.4	35.3	38.3	40.4	38.2
	54.8	39.3	31.5	28.0	22.5	19.3	31.7	34.0	33.0	36.4	38.9	36.8
Profit
	64.7	48.1	38.0	35.4	31.5	26.4	36.5	40.7	37.6	40.0	43.6	40.4
	64.7	48.1	38.0	35.4	31.5	26.4	36.5	40.7	37.6	40.0	43.6	40.4
	16.9	5.4	8.5	7.7	5.0	5.2	7.9	8.1	8.1	8.6	10.3	8.8
	−0.4	−1.1	−0.5	1.6	1.4	1.1	0.8	0.6	0.3	0.9	0.3	0.1
	16.5	4.3	7.9	9.3	6.5	6.3	8.7	8.6	8.5	9.5	10.6	8.9
	48.2	43.8	30.1	26.1	25.0	20.1	27.8	32.1	29.2	30.5	32.9	31.5
	48.2	43.8	30.1	26.1	25.0	20.1	27.8	32.1	29.2	30.5	32.9	31.5
	0.1	0.2	0.0	0.1	−0.0	0.2	−0.1	−0.0	−0.1	−0.2	0.0	0.0
	48.3	44.0	30.2	26.1	25.0	20.3	27.8	32.0	29.1	30.2	32.9	31.5
	38.4	31.6	26.3	26.0	24.8	20.0	27.6	31.9	28.8	30.1	32.7	31.4
	9.8	12.2	3.8	0.1	0.2	0.2	0.2	0.2	0.4	0.4	0.3	0.1
Per share
	₹0.41	₹0.38	₹0.26	₹2.27	₹2.18	₹1.76	₹2.43	₹2.80	₹2.56	₹2.72	₹2.95	₹2.83
	₹0.41	₹0.38	₹0.26	₹2.27	₹2.18	₹1.76	₹2.43	₹2.80	₹2.56	₹2.72	₹2.95	₹2.83
Other comprehensive income — detail
	0.1	0.2	0.0	0.1	−0.0	0.2	—	—	—	—	—	—
	−0.1	−0.2	−0.0	−0.1	0.0	−0.2	—	—	—	—	—	—
	—	—	—	—	—	—	0.1	0.0	0.1	0.2	0.0	−0.0
	—	—	—	—	—	—	0.0	0.0	0.0	0.0	−0.0	0.0
	38.5	31.8	26.4	26.0	24.8	20.1	27.6	31.8	28.7	29.9	32.7	31.4
	9.8	12.2	3.8	0.1	0.2	0.2	0.2	0.2	0.4	0.4	0.3	0.1
Per share — as-filed variants
	₹0.41	₹0.38	₹0.26	₹2.27	₹2.18	₹1.76	₹2.43	₹2.80	₹2.56	₹2.72	₹2.95	₹2.83
	₹0.41	₹0.38	₹0.26	₹2.27	₹2.18	₹1.76	₹2.43	₹2.80	₹2.56	₹2.72	₹2.95	₹2.83
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	133	91.2	64.7	52.9	46.0	43.4	51.9	55.7	54.8	57.8	57.4	56.2
	35.4%	29.1%	35.2%	38.5%	33.5%	36.2%	41.2%	38.2%	38.6%	37.8%	41.5%	38.7%
Adjusted (ex-exceptional items) — derived
	64.7	48.1	38.0	35.4	31.5	26.4	36.5	40.7	37.6	40.0	43.6	40.4
	48.2	43.8	30.1	26.1	25.0	20.1	27.8	32.1	29.2	30.5	32.9	31.5
	₹0.41	₹0.38	₹0.26	₹2.27	₹2.18	₹1.76	₹2.43	₹2.80	₹2.56	₹2.72	₹2.95	₹2.83

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

FCL₹51.19

Fineotex Chemical Limited

· Chemicals

Annual Quarterly₹ CrorePeersEPIGRAL YASHO GUJALKALI FOSECOIND VISHNU GALAXYSURF TATVA JUBLCPLMcap ₹5,961 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	145.3	138.5	153.0	141.9	145.7	125.9	119.8	137.1	137.7	183.7	313.7	376.6
Other Income	3.8	4.9	4.1	4.9	6.9	5.0	7.5	9.1	7.7	6.7	9.5	10.1
Total Income	149.1	143.4	157.2	146.8	152.6	130.9	127.3	146.2	145.4	190.5	323.2	386.7
Expenses
+ Cost of Materials Consumed	83.9	78.9	95.6	93.0	83.0	79.3	83.5	82.8	88.3	116.5	224.7	248.3
+ Purchases of Stock-in-Trade	6.5	3.1	3.2	0.3	5.0	2.0	-4.4	8.6	2.6	6.0	0.9	0.0
+ Changes in Inventories	-1.4	-1.0	-3.6	-6.2	2.0	-7.2	-2.7	-0.2	-6.2	-3.6	-3.1	-5.1
+ Employee Benefit Expense	5.0	5.5	5.5	5.6	6.1	6.1	6.5	6.2	6.5	10.3	17.4	26.8
+ Finance Costs	0.3	0.3	0.6	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.6	0.1
+ Depreciation & Amortisation	1.4	1.4	1.9	2.2	2.4	2.6	2.0	2.7	3.0	3.3	4.4	4.4
+ Other Expenses	12.9	11.6	14.0	13.9	13.2	11.5	15.6	14.6	15.4	19.6	30.1	47.4
Total Expenses	108.7	99.8	117.2	109.1	111.9	94.4	100.9	114.7	110.0	152.4	275.1	322.0
EBITDA	38.2	40.4	38.3	35.3	36.4	34.3	21.3	25.2	31.0	34.8	43.7	59.1
EBIT	36.8	38.9	36.4	33.0	34.0	31.7	19.3	22.5	28.0	31.5	39.3	54.8
Profit
PBT before Exceptional Items	40.4	43.6	40.0	37.6	40.7	36.5	26.4	31.5	35.4	38.0	48.1	64.7
Pretax Income	40.4	43.6	40.0	37.6	40.7	36.5	26.4	31.5	35.4	38.0	48.1	64.7
+ Current Tax	8.8	10.3	8.6	8.1	8.1	7.9	5.2	5.0	7.7	8.5	5.4	16.9
+ Deferred Tax	0.1	0.3	0.9	0.3	0.6	0.8	1.1	1.4	1.6	-0.5	-1.1	-0.4
Tax Expense	8.9	10.6	9.5	8.5	8.6	8.7	6.3	6.5	9.3	7.9	4.3	16.5
Net Income	31.5	32.9	30.5	29.2	32.1	27.8	20.1	25.0	26.1	30.1	43.8	48.2
+ Net Income — Continuing Ops	31.5	32.9	30.5	29.2	32.1	27.8	20.1	25.0	26.1	30.1	43.8	48.2
+ Other Comprehensive Income	0.0	0.0	-0.2	-0.1	-0.0	-0.1	0.2	-0.0	0.1	0.0	0.2	0.1
Total Comprehensive Income	31.5	32.9	30.2	29.1	32.0	27.8	20.3	25.0	26.1	30.2	44.0	48.3
Net Income to Common	31.4	32.7	30.1	28.8	31.9	27.6	20.0	24.8	26.0	26.3	31.6	38.4
Minority Interest	0.1	0.3	0.4	0.4	0.2	0.2	0.2	0.2	0.1	3.8	12.2	9.8
Per Share
Basic EPS	2.83	2.95	2.72	2.56	2.80	2.43	1.76	2.18	2.27	0.26	0.38	0.41
Diluted EPS	2.83	2.95	2.72	2.56	2.80	2.43	1.76	2.18	2.27	0.26	0.38	0.41
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	0.2	-0.0	0.1	0.0	0.2	0.1
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	-0.2	0.0	-0.1	-0.0	-0.2	-0.1
+ Tax on Items NOT to be Reclassified — alt tag	-0.0	0.0	0.2	0.1	0.0	0.1	—	—	—	—	—	—
+ Tax on Items to be Reclassified — alt tag	0.0	-0.0	0.0	0.0	0.0	0.0	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	31.4	32.7	29.9	28.7	31.8	27.6	20.1	24.8	26.0	26.4	31.8	38.5
Comprehensive Income — Non-controlling Interests	0.1	0.3	0.4	0.4	0.2	0.2	0.2	0.2	0.1	3.8	12.2	9.8
Per Share — as-filed variants
Basic EPS — Continuing Operations	2.83	2.95	2.72	2.56	2.80	2.43	1.76	2.18	2.27	0.26	0.38	0.41
Diluted EPS — Continuing Operations	2.83	2.95	2.72	2.56	2.80	2.43	1.76	2.18	2.27	0.26	0.38	0.41
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	56.2	57.4	57.8	54.8	55.7	51.9	43.4	46.0	52.9	64.7	91.2	133.4
Gross Margin %	38.66	41.47	37.78	38.58	38.22	41.19	36.22	33.53	38.45	35.24	29.07	35.42
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	40.4	43.6	40.0	37.6	40.7	36.5	26.4	31.5	35.4	38.0	48.1	64.7
Net Income Adj (tax-effected)	31.5	32.9	30.5	29.2	32.1	27.8	20.1	25.0	26.1	30.1	43.8	48.2
EPS Adj	2.83	2.95	2.72	2.56	2.80	2.43	1.76	2.18	2.27	0.26	0.38	0.41
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	1.00	1.00	1.00
Paid Up Equity Capital	22.1	22.2	22.2	22.5	23.2	23.2	22.9	22.9	22.9	116.0	116.5	116.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Fineotex Chemical quarterly results

Fineotex Chemical (NSE: FCL) has not yet announced the date of its Q2 FY27 results (July–September 2026); they are due by 14 November 2026 under SEBI's 45-day rule. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit attributable to shareholders was ₹38.4 crore, up 54.8% from ₹24.8 crore in Q1 FY26 and up 21.5% from ₹31.6 crore in Q4 FY26. Revenue from operations was ₹377 crore, up 174.8% year on year and up 20.0% from the previous quarter.

Q2 FY26 results (a year earlier): 14 November 2025
Q1 FY27 results (the latest): 23 July 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results due by: 14 November 202645 days after the quarter (SEBI)
Q1 FY27 net profit: ₹38.4 Cr+54.8% vs Q1 FY26+21.5% vs Q4 FY26
Q1 FY27 revenue: ₹377 Cr+174.8% vs Q1 FY26+20.0% vs Q4 FY26
Q1 FY27 operating margin: 14.5%−1.9 pts vs Q1 FY26+2.0 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹26 CrRevenue ₹138 Cr
Q1 FY27 EPS (basic): ₹0.41

Questions

When will Fineotex Chemical announce its Q2 FY27 results?

The date is not announced yet. Results for July–September 2026 are due by 14 November 2026 (45 days after the quarter, SEBI Regulation 33). Last year it reported Q2 FY26 on 14 November 2025.

What will Fineotex Chemical's Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit attributable to shareholders was ₹26 crore and revenue from operations ₹138 crore. The latest quarter, Q1 FY27, had a net profit of ₹38.4 crore and revenue of ₹377 crore.

What were Fineotex Chemical's Q1 FY27 results?

Consolidated net profit attributable to shareholders was ₹38.4 crore, up 54.8% from ₹24.8 crore in Q1 FY26 and up 21.5% from ₹31.6 crore in Q4 FY26. Revenue from operations was ₹377 crore, up 174.8% year on year and up 20.0% from the previous quarter.

How has Fineotex Chemical's profit changed over the last four quarters?

Net profit attributable to shareholders by quarter: ₹26 crore in Q2 FY26, ₹26.3 crore in Q3 FY26, ₹31.6 crore in Q4 FY26 and ₹38.4 crore in Q1 FY27. That is ₹122 crore over the four quarters, up 17.3% from ₹104 crore in the four quarters before. Revenue from operations: ₹138 crore, ₹184 crore, ₹314 crore and ₹377 crore.

What was Fineotex Chemical's net profit in FY26?

Consolidated net profit attributable to shareholders was ₹109 crore in FY26 (April 2025–March 2026), up 0.5% from ₹108 crore in FY25. It was ₹120 crore in FY24 and ₹88.3 crore in FY23: up 23.1% over three years, 7.2% a year on average.

What was Fineotex Chemical's revenue in FY26?

Revenue from operations was ₹772 crore in FY26 (April 2025–March 2026), up 44.8% from ₹533 crore in FY25. It was ₹569 crore in FY24 and ₹517 crore in FY23: up 49.4% over three years, 14.3% a year on average.

Where do these Fineotex Chemical figures come from?

From Fineotex Chemical's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.